Sandoz stock trades 4.16 percent above its Xetra close

Published on 10/26/2026 at 17:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half biosimilar sales grew 20.00 percent. Sandoz stock costs EUR 89.45 on October 26, 2026, up 4.16 percent versus the Xetra close.

Price move and operating figures

Sandoz stock traded 4.16 percent above the Xetra close on October 26, 2026.
First-half net sales increased 5.00 percent and biosimilar sales grew 20.00 percent.
Sandoz stock cost EUR 89.45 at Lang & Schwarz on October 26, 2026 at 5:15 p.m. CEST, 4.16 percent above the EUR 85.88 Xetra close of October 23, 2026.
The next sales and revenue release is scheduled for October 27, 2026.

Sandoz, CH1243598427, Illustration mit AI erstellt.

Sandoz stock (ISIN CH1243598427) was trading at EUR 89.45 at Lang & Schwarz on October 26, 2026 at 5:15 p.m. CEST, up 4.16 percent versus the Xetra close of October 23, 2026 at EUR 85.88. The move comes as investors assess the company's latest operating figures ahead of its next scheduled sales update.

Biosimilars drove first-half growth

According to Yahoo Finance on August 5, 2026, Sandoz reported a 5.00 percent increase in first-half net sales, while second-quarter growth reached 7.00 percent. Biosimilar sales increased 20.00 percent in the first half and accounted for 33.00 percent of net sales.

The earnings call also put profitability in sharper relief. Core EBITDA increased 15.00 percent in the first half, and the core EBITDA margin expanded by 0.90 percentage points to 20.90 percent. Core diluted earnings per share rose 17.00 percent to USD 1.71 for the period.

The euro quote moved above Friday's close

The current euro quotation stands EUR 3.57 above the EUR 85.88 Xetra close, a gain of 4.16 percent calculated from those two values. Sandoz's market capitalization was EUR 38.0 billion as of October 23, 2026, while its primary listing is on SIX under ticker SDZ.

What comes next on October 27?

MarketScreener lists October 27, 2026 as the date for Sandoz's sales and revenue release covering the third quarter of 2026. That publication will provide the next periodized read on sales momentum and whether biosimilars continued to offset pricing pressure.

Sandoz stock stays above the Xetra close

At Lang & Schwarz, Sandoz stock was trading at EUR 89.45 on October 26, 2026 at 5:15 p.m. CEST, up 4.16 percent versus the Xetra close of October 23, 2026 at EUR 85.88.

The further course of trading is shown by the continuously updated real-time quote of Sandoz stock.